Drug Shortage Report for JAMP-ZOLEDRONIC ACID

Last updated on 2023-10-18 History
Report ID 180271
Drug Identification Number 02482525
Brand name JAMP-ZOLEDRONIC ACID
Common or Proper name Zoledronic Acid for Injection
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-09
Estimated end date 2023-10-15
Actual end date 2023-10-10
Shortage status Resolved
Updated date 2023-10-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2023-10-18 French Compare
v25 2023-10-18 English Compare
v24 2023-10-18 French Compare
v23 2023-10-18 English Compare
v22 2023-09-26 French Compare
v21 2023-09-26 English Compare
v20 2023-09-11 French Compare
v19 2023-09-11 English Compare
v18 2023-08-25 French Compare
v17 2023-08-25 English Compare
v16 2023-08-08 French Compare
v15 2023-08-08 English Compare
v14 2023-07-17 French Compare
v13 2023-07-17 English Compare
v12 2023-07-03 French Compare
v11 2023-07-03 English Compare
v10 2023-06-22 French Compare
v9 2023-06-22 English Compare
v8 2023-04-12 French Compare
v7 2023-04-12 English Compare

Showing 1 to 20 of 26